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Purpose: To study the roles played by stem cell factor (SCF) and SCF receptor c-kit in wound healing of corneal epithelial
cells.
Methods: A 2 mm corneal epithelial wound was made in control (WBB6F1+/+), SCF (Sl/Sld)-, and c-kit (W/Wv) mutant
mice, and the speed of wound healing, 5-bromo-2’-deoxyuridine (BrdU) incorporation, and scanning electron microscopic
(SEM) morphology of the corneas were examined. The incorporation of BrdU and the degree of cell attachment in cultured
mouse corneal epithelial cells (MCECs) isolated from WBB6F1+/+, Sl/Sld, and W/Wv mice were examined. Cultured
immortalized human corneal epithelial cells (HCECs) were examined by a cell attachment assay after their exposure to
anti-SCF antibodies, tyrosine kinase inhibitor (genistein), and competitive Arg-Gly-Asp (RGD) peptide, as well as on
cultures treated with extracellular matrix.
Results: The speed of corneal wound healing was slower in Sl/Sld and W/Wv mice than in controls (p<0.01) and the speed
of healing in Sl/Sld mice recovered after topical application of SCF (8 ng/ml). No significant difference was found in the
BrdU incorporation assay either in vivo or in vitro. Loosened epithelial cells were detected at wound margins in W/Wv
mice by SEM. The cell attachment rate was increased by 157% in cells from WBB6F1+/+ and 252% in Sl/Sld MCECs by
recombinant mouse SCF; however, no significant difference was found in W/Wv MCECs. Anti-SCF antibodies (Ab),
genistein, and RGD peptide reduced the percentage of attached HCECs. Anti-SCF Ab inhibited the attachment of HCECs
on fibronectin, laminin, or type IV collagen coated dishes.
Conclusions: These findings indicate that the SCF/c-kit system may play a role in corneal wound healing through epithelial
cell attachment.
Stem cell factor (SCF), also called c-kit ligand, steel
factor, and mast cell growth factor, is composed of 164 amino
acids and has a molecular weight of 30 kDa. It exists in soluble
and  membrane-bound  forms  [1-4].  SCF  signals  are
transmitted by the c-kit receptor, which belongs to the same
subfamily of tyrosine kinases receptors as platelet-derived
growth factor (PDGF) and granulocyte macrophage colony-
stimulating  factor  (GM-CSF)  [2-5].  c-kit  has  an
immunoglobulin-like  structure  in  the  extracellular  domain
and a tyrosine kinase-like structure in the cytoplasmic domain.
The tyrosine kinase activity of this receptor is tightly regulated
by  SCF  and  is  known  to  play  a  crucial  role  in  signal
transduction  pathways  involved  in  the  growth  and
differentiation of various cells [6-10]. c-kit is distributed in
such tissues as bone marrow, spleen, thymus, skin, and testis,
while  SCF  is  expressed  in  placental  tissue,  bone  marrow
stromal cells, venous endothelial cells, fibroblasts, and Sertoli
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cells [11-13]. The SCF/c-kit system functions mainly in the
stimulation  and  maturation  of  myeloid,  erythroid,  and
lymphoid progenitors, and in the differentiation and growth
of melanocytes, germ cells, and mast cells [6,9,10,14-16].
Recent studies have demonstrated that epithelial cells
express  SCF  and/or  c-kit  and  the  SCF/c-kit  system  has
important functional roles in epithelial cells. Thus, ovarian
surface epithelial cells express SCF and c-kit, suggesting that
they are involved in normal ovarian surface epithelial biology
as well as ovarian cancer [17]. In the skin, SCF and c-kit are
expressed in mast cells, melanocytes, and epithelial cells, and
they are involved in epithelial wound healing, melanocyte
proliferation and migration, and hair cycling [18-20]. The
SCF/c-kit  system  is  also  involved  in  the  regenerative
processes in the liver [21].
However, there have been only three studies that have
examined the SCF in ocular tissues: infiltrating fibroblasts in
pterygia, choroidal melanocytes, and iris pigment epithelial
cells [22-24]. However, the localization and function of the
SCF/c-kit  system  in  ocular  surface  tissues  are  still
undetermined.
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1505The SCF is located at the steel (Sl) locus on chromosome
12 in humans and on chromosome 10 in mice, and c-kit at the
white spotting (W) locus of chromosome 4 in humans and on
mouse chromosome 5 [25-29]. A complete loss of SCF or c-
kit function is lethal, but mice with mutations at either of these
alleles  (Sl/Sld  and  W/Wv)  show  similar  defects  in
hematopoiesis, gametogenesis, and melanogenesis [30-32].
Mice  with  mutations  at  either  locus  typically  have
unpigmented  coats,  are  sterile,  and  are  deficient  in
erythrocytes and mast cells, as well as the precursors for
multiple hematopoietic lineages. Thus, these mice have been
used to investigate the SCF/c-kit system [12,30,31,33,34].
The  purpose  of  this  study  was  to  determine  the
localization of SCF and c-kit in the mouse cornea, and to
examine  what  role  they  play  in  corneal  epithelial  wound
healing.  To  accomplish  this,  we  first  investigated  corneal
wound healing in both Sl/Sld- and W/Wv–mutant mice in vivo.
We also examined cultured mouse corneal epithelial cells
isolated from Sl/Sld and W/Wv mice.
METHODS
Animals: We used WBB6F1-Sl/Sld and [29] WBB6F1-W/
Wv [28] mice and WBB6F1+/+ mice for control. Genotypes of
mutant  mice  were  determined  by  SLC,  Inc.  (Hamamatsu,
Japan). All of the mice were purchased from SLC, Inc. and
housed  in  conformity  with  the  Statement  on  the  Use  of
Animals at Ehime University School of Medicine. Mice were
gender-matched for the experiments and used at 6 to 10weeks
of  age.  All  mice  were  handled  in  accordance  with  the
guidelines in the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
Measurement of corneal wound healing in SCF and C-kit
mutant mice: Mice were anesthetized by an intraperitoneal
injection of phenobarbital (50 mg/kg). There were 5 animals
in each group, viz., the SCF mutant (Sl/Sld), c-kit mutant (W/
Wv), and control WBB6F1-+/+ mice. A 2 mm central corneal
epithelial defect was made on one eye with an excimer laser
(EC-5000; NIDEK, Shizuoka, Japan), and the depth of wound
was standardized at 30 µm. Corneas were stained with 0.4%
methylene blue in phosphate-buffered saline (PBS), and the
injured area was photographed at 6, 12, 18, 24, 30, 36, 42, and
48 h after creating the epithelial injury. The size of the injured
area  was  measured  on  the  images  by  Canvas™  ver  6.0
(Deneba software, Miami, FL).
In vivo 5-bromo-2’-deoxyuridine (BrdU) incorporation: In
addition to assessing the degree of wound healing, animals
(n=6 for each genotype and for each time point) were injected
intraperitoneally with 8 mg/µl (200 µg/g bodyweight) of 5-
bromo-2’-deoxyuridine (Sigma-Aldrich, St. Louis, MO) in
PBS 2 h before euthanasia.
RNA extraction and reverse transcription-polymerase chain
reaction  (RT–PCR):  Total  RNA  was  extracted  from  the
corneas excised from WBB6F1+/+ mice using the RNeasy kit
(Qiagen, Valencia, CA) and then reverse-transcribed using
Omniscript Reverse Transcriptase (Qiagen) according to the
manufacturer’s protocol. The extracts were divided into tubes
containing PCR reaction mixture (AmpliTaq Gold; Applied
Biosystems, Inc., Tokyo, Japan) with specific primers (Table
1).
The  mixture  was  amplified  with  the  TaKaRa  PCR
Thermal Cycler (TAKARA BIO Inc., Otsu, Japan): 40 cycles
of 30 s at 94 °C, 30 s at 58 °C, and 1 min at 72 °C, followed
by extension at 72 °C for 7 min. Then 5 µl of this solution was
electrophoresced on 1.5% agarose gel and stained with 1 µg/
ml of ethidium bromide and viewed with a transilluminator.
Immunohistochemistry: For immunostaining of SCF and c-
kit, corneas were fixed in periodate-lysine-paraformaldehyde
containing 4% sodium metaperiodate for 30 min and placed
in 10% sucrose overnight. Samples were frozen and cut into
7 µm sections. For immunostaining for BrdU, eyes were fixed
in 4% paraformaldehyde in PBS overnight and embedded in
paraffin. Then 5 µm sections were cut, deparaffinized, and
rehydrated. After the endogenous peroxidase was blocked
with 0.3% hydrogen peroxidase for 20 min, sections were
incubated with anti-mouse c-kit rabbit IgG (0.5 µg/ml; Santa
Cruz, Santa Cruz, CA), anti-mouse SCF rabbit IgG (1.3 µg/
ml, Genzyme, Cambridge, MA), or anti-BrdU monoclonal
antibody (0.5 µg/ml, Lab Vision, Fremont, CA) for 24 h at
4 °C. The sections were developed with the peroxidase-DAB
method using PAPKIT™ (ZYMED, San Francisco, CA) or
M.O.M.™  immunodetection  kits  (Vector  Laboratories,
Burlingame,  CA)  according  to  the  manufacturer’s
instructions. Isotype-matched, irrelevant antibodies were used
to rule out false positives for each immunostained group.
TABLE 1. SEQUENCES OF PRIMERS USED IN RT–PCR.
Primer Sequence (5′-3′) Product size (bp) GenBank number
SCF F-TCATGGTGCACCGTATCCTA 170 bp NM_013598
  R-CCTTGGCATGTTCTTCCACT    
c-kit F-GGGCTAGCCAGAGACATCAG 160 bp NM_001122733
  R-AGGAGAAGAGCTCCCAGAGG   NM_021099
β-actin F-CCTGTATGCCTCTGGTCGTA 260 bp NM_007393
  R-CCATCTCCTGCTCGAAGTCT    
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A 2 mm corneal epithelial defect was created on one eye of
each mouse of the three groups as described above, and 8 ng/
ml of recombinant mouse SCF (rmSCF, Genzyme) in 5 µl of
PBS was applied every 6 h for up to 48 h. As control, an
identical number of mice were given 5 µl of PBS-BSA (BSA)
of the same protein concentration as the rmSCF. The injured
corneas were photographed every 6 h and size of the injured
area was measured as described above.
Scanning electron microscopy (SEM): Corneas were removed
at 6, 12, and 24 h after the epithelial injury from WBB6F1+/+
and W/Wv mice for scanning electron microscopy (SEM). The
corneas  were  pre-fixed  in  2.5%  glutaraldehyde  in  0.1  M
cacodylate  buffer  (pH  7.4)  for  2  h,  then  washed  with
cacodylate buffer, immersed in 1% tannic acid for 1 h, washed
again with cacodylate buffer, and post-fixed with 2% osmium
tetroxide in cacodylate buffer for 2 h. The corneas were then
washed with distilled water, dehydrated in a graded ethanol
series, and dried using the critical point drying method. The
processed corneas were examined with SEM (Hitachi S-800;
Hitachi, Tokyo, Japan).
In vitro assay of BrdU incorporation and attachment of mouse
corneal epithelial cells (MCECs): Mouse corneal epithelial
cells (MCECs) from WBB6F1+/+, -Sl/Sld, and -W/Wv mice
were cultured as described [35]. The MCECs were in low-
bovine pituitary extract medium CnT-50 (CELLnTEC, Bern,
Switzerland), and the subconfluent cells at passage 3 (P3)
were incubated in a growth factor starvation medium, CnT-20
(CELLnTEC),  supplemented  with  5  µg/ml  of  insulin
(Invitrogen, Inc., Tokyo, Japan) for 24 h. After the growth
factor starvation, MCECs were trypsinized into single cells
for  the  BrdU  incorporation  assay  and  the  cell  attachment
assay.
For  the  BrdU  incorporation  assay,  the  MCECs  were
resuspended in the starvation medium supplemented or not
supplemented  with  10  ng/ml  of  rmSCF  (R&D  Systems,
Minneapolis, MN), seeded into 24 well tissue culture plates
(Asahi  Techno  Glass,  Funabashi,  Japan)  at  a  density  of
2×104 cells/cm2, and incubated for 48 h at 37 °C under 95%
humidity and 5% CO2. After incubation, the DNA synthetic
activity of MCECs was measured with the BrdU Labeling and
Detection Kit II (Roche Diagnostics, Tokyo, Japan) according
to  the  manufacturer’s  instructions.  In  brief,  the  culture
medium was changed to the same fresh medium containing
BrdU labeling reagent (1:1000) and incubated for 60 min at
37 °C under 95% humidity and 5% CO2. The MCECs were
fixed in 70% ethanol buffered with 50 mM glycine buffer (pH
2, −20 °C), and then washed and incubated with a monoclonal
anti-BrdU.  The  labeled  cells  were  made  visible  by
fluorescein-conjugated anti-mouse immunoglobulin (Vector
Laboratories,  Burlingame,  CA).  The  nuclei  were  counter-
stained with hoechst, and the total number of cells and the
number  of  BrdU-positive  nuclei  were  counted  under  a
fluorescence  microscope  (IX70:  Olympus,  Tokyo,  Japan).
The  BrdU  incorporation  is  presented  as  the  number  of
positively stained nuclei relative to the total number of cells.
For  the  cell  attachment  assay,  the  MCECs  were
resuspended in the starvation medium supplemented or not
supplemented with 1, 10, or 30 ng/ml of rmSCF, seeded on to
96 well tissue culture plates (Corning, Inc., Corning, NY) at
a density of 5×104 cells/well, and incubated for 2 h at 37 °C
under 95% humidity and 5% CO2. After incubation, the wells
were washed twice with PBS(-), and the attached MCECs
were  trypsinized  into  single  cells.  The  number  of  cells
attached  to  the  plates  was  counted  using  an  improved
Neubauer counting chamber. The number of attached cells is
presented as the number of attached cells relative to the non-
SCF control.
In  vitro  assay  of  cell  attachment  of  immortalized  human
corneal  epithelial  cells  (HCECs):  Immortalized  human
corneal  epithelial  cells  (HCECs)  were  grown  to  100%
confluence  in  supplemented  hormonal  epithelial  medium
consisting of Dulbecco's modified eagle medium (DMEM)
with low glucose/F-12 (Invitrogen, Carlsbad, CA), 15% fetal
bovine  serum  (FBS),  10  ng/ml  epidermal  growth  factor
(Invitrogen), 5 µg/ml insulin (Invitrogen), 5 mM L-glutamine
(Invitrogen), 0.5% dimethyl sulfoxide (Sigma, St Louis, MO),
and gentamicin (Invitrogen) [36]. All cells were grown at
37 °C in a humidified environment with 5% CO2. The culture
medium was changed every 2 to 3 days.
To examine the involvement of SCF, the HCECs were
resuspended in the starvation medium supplemented with 0,
10, 50, 250, or 1,000 ng/ml of anti-human goat SCF antibody
(Santa Cruz) or control goat IgG (Santa Cruz), seeded on to
96 well tissue culture plates (Corning, Inc., Corning, NY) at
a density of 5×104 cells/well, and incubated for 2 h at 37 °C
under 95% humidity and 5% CO2. After incubation, the wells
were washed twice with PBS(-), and the attached HCECs were
counted  as  described.  To  determine  the  involvement  of
intracellular signaling transduction by c-kit, the HCECs were
resuspended in the starvation medium supplemented or not
supplemented  with  5,  10,  25,  and  50  µg/ml  of  genistein
(Invitrogen),  a  tyrosine  kinase  inhibitor.  To  examine  the
involvement of integrins in cell attachment, the HCECs were
resuspended with or without 125, 250, 500, and 1,000 µg/ml
of  GRGDSP  or  GRGESP  peptide  (SIGMA-ALDRICH,
Ishikari,  Japan).  To  examine  the  involvement  of  the
extracellular matrix, which has integrin binding RGD regions,
the HCECs were resuspended with 1000 ng/ml of anti-human
goat SCF antibodies or control goat IgG, and seeded on to
tissue culture plates treated with fibronectin, laminin, or type
IV collagen (Asahi Techno Glass, Funabashi, Japan). The
number  of  attached  cells  is  presented  as  the  number  of
attached cells relative to the cells in the control.
Statistical  analyses:  Statistical  analyses  to  determine  the
significance  of  the  differences  between  the  experimental
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significance level was set at p<0.05.
RESULTS
Distribution of SCF and c-kit in ocular surface tissues: To
determine whether SCF and c-kit were present in the cornea,
we  performed  RT–PCR  and  immunohistochemistry  on
corneas obtained from WBB6F1+/+ mice. Both SCF and c-kit
mRNAs  were  detected  in  the  corneal  tissue  (Figure  1A).
Immunohistochemistry  showed  that  SCF  was  strongly
expressed uniformly in the epithelia cells (Figure 1B), and c-
kit was also expressed corneal epithelia, especially in the basal
cells (Figure 1C). The c-kit receptor was expressed in both the
central and peripheral cornea.
Corneal epithelial wound closure in SCF- and C-kit mutant
mice: We examined the speed of corneal epithelial wound
healing in ligand- or receptor-deficient mutant mice. The rate
of wound healing in the ligand-deficient (Sl/Sld) mice and the
receptor-deficient  (W/Wv)  mice  was  significantly  delayed
compared to that of the control WBB6F1+/+ mice (Figure 2A).
The delay was significant even at 12 h after the epithelial
injury when the Sl/Sld was 49% and the W/Wv mice was 47%
of that of the controls (both p<0.01). In control WBB6F1+/+
mice, the wounds were almost completely closed at 42 h,
Figure 1. Expression of SCF and c-kit in
mouse  cornea.  A:  Expression  of  the
mRNAs  of  SCF  and  c-kit  in  mouse
cornea.  Total  mRNA  was  extracted
from  cornea  and  brain  tissues  of
WBB6F1-+/+mice. The mRNAs of SCF
and c-kit were detected in corneal tissue
with the predicted size of approximately
170  and  160  base  pairs,  respectively.
The brain was used as positive control
(P). Negative control was carried with
no DNA template (N). C:Cornea. B, C:
Immunohistochemical detection of SCF
and  c-kit  in  mouse  cornea.  Corneal
tissues from WBB6F1-+/+ were stained
with anti-mouse SCF rabbit IgG (B) or
anti-mouse c-kit rabbit IgG (C). In the
cornea, a staining for SCF and c-kit was
observed  throughout  the  epithelium.
Bar: 50 µm.
Figure 2. Corneal epithelial wound healing of W/Wv- and Sl/Sld mutant mice. A 2 mm corneal epithelial defect was made, and degree of
recovery was measured every 6 h. Compared to WBB6F1+/+ mice, the epithelial wound healing rates of both c-kit mutant mice and SCF mutant
mice are significantly delayed (A). To determine the effect of topical rmSCF application on corneal epithelial wound healing, 5 µl of rmSCF
(8 ng/ml) was applied topically to the wounded cornea every 6 h in WBB6F1+/+ (B) and SCF mutant mice (C). The difference in the percentage
of recovery is significant between WBB6F1+/+ (B) and SCF mutant (C) mice. +/+=WBB6F1+/+ mice, W/Wv=c-kit mutant mice, Sl/Sld=SCF
mutant mice. The error bars represent the standard errors (SE) from three experiments. *p<0.01 (paired students’ t test) against WBB6F1+/+
mice or non-administrated controls.
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in the W/Wv mice.
Topical administration of recombinant SCF on wound healing
of cornea: To determine whether topical application of SCF
will enhance corneal wound healing, we applied recombinant
SCF topically to the injured cornea of WBB6F1+/+ and Sl/Sld
mice. The healing speed was accelerated by topical SCF in
both  WBB6F1+/+  and  Sl/Sld  mice  within  12  h  after  the
application (Figure 2B,C). The healing speed was especially
prominent from the initial application up to 12 h after the SCF
eyedrops; the residual defect area was 49% (untreated 64%)
for WBB6F1+/+ mice and 63% (untreated 83%) for Sl/Sld at 12
h after debridement.
BrdU  incorporation  during  wound  healing:  To  determine
whether the SCF/c-kit pathway enhances corneal epithelial
cell proliferation during wound healing, the incorporation of
BrdU  by  epithelial  cells  was  determined  during  wound
healing in WBB6F1+/+ and W/Wv mice. The number of BrdU-
positive cells was significantly increased 24 h after excimer
laser injury in WBB6F1+/+ (57.5±3.4 cells/section, n=6) and
in W/Wv (54.6±2.3 cells/section, n=6). The difference in the
number of labeled cells was not significant between the two
genotypes (Figure 3).
Scanning electron microscopy: Scanning electron microscopy
was used to examine the leading edges of the corneal epithelial
cells during wound closure in WBB6F1+/+ and W/Wv mice
(Figure 4). The difference between the WBB6F1+/+ and W/
Wv mice was clearly seen in the images at 24 h after epithelial
injury. There were loosened cells in the W/Wv mouse cornea
at 24 h after wounding, while the leading edge of WBB6F1+/
+ mice cornea appeared to be firmly attached to the basement
membrane.
In vitro assay of BrdU incorporation: To confirm the effect
of SCF on the proliferation of the mouse corneal epithelial
cells (MCECs), the incorporation of BrdU in the cultured
MCECs was measured with or without addition of rmSCF to
the culture medium. As in the in vivo assay, exposure to
rmSCF did not accelerate the DNA synthetic activities in the
WBB6F1+/+, SCF mutant Sl/Sld, and c-kit mutant W/Wv mice
(Figure 5). The BrdU-positive cells in the rmSCF-stimulated
cultures from WBB6F1+/+, Sl/Sld, and W/Wv mice were 83%,
102%, and 87% of the non-stimulated controls, respectively.
There was no significant difference in these values between
the rmSCF-stimulated cells and the non-stimulated controls
(p>0.05, Man-Whitney U-test; Figure 5).
In vitro assay of cell attachment of mouse corneal epithelial
cells (MCECs): Exposure to rmSCF significantly enhanced
the  attachment  of  MCECs  from  WBB6F1+/+  mice  to  the
culture  plates.  With  1,  10,  and  30  ng/ml  of  rmSCF,  the
percentages of attached cells were 128%, 139%, and 157%,
respectively, of the non-stimulated control (Figure 6). rmSCF
exposure also enhanced the attachment of cells from SCF
mutant Sl/Sld mice, and the attached cells that were stimulated
increased from 177% to 252% of the control (Figure 6). On
the other hand, rmSCF had no influence on the attachment of
c-kit mutant cells from W/Wv mice; the attached percentage
ranged from 100% to 112% of the control, which was not
significantly different from that of the non-stimulated control
(Figure 6).
In vitro assay of attachment of human corneal epithelial cells
(HCECs):  Anti-SCF  antibodies  significantly  reduce  the
percentage of attached HCECs. The percentages of attached
cells that were incubated with 10, 50, 250, or 1,000 ng/ml of
anti-SCF antibodies were 76.9%, 69.9%, 61.5%, and 43.6%,
respectively, of the control (Figure 7A). The tyrosine kinase
Figure  3.  In  vivo  assay  of  BrdU
incorporation during corneal epithelial
wound healing. BrdU-positive corneal
epithelial cells were counted in sections
of WBB6F1+/+ and c-kit mutant corneas.
Although  the  number  of  BrdU
incorporated  cells  gradually  increased
after the injury, there were no significant
differences between WBB6F1+/+ and c-
kit  mutant  mice  at  each  time  point
(unpaired  t  tests).  +/+=WBB6F1+/+
mice, W/Wv=c-kit mutant mice. Error
bars represent the standard errors (n=6).
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The numbers of attached cells that were incubated with 25 and
50 µg/ml of genistein were significantly reduced to 89.5% and
62.5%, respectively, of the control (Figure 7B). The RGD
peptide also reduced the percentage of HCECs attached. The
attached cells that were incubated with 500 and 1000 µg/ml
of GRGDSP peptide were also significantly reduced to 61.5%
and  45.0%,  respectively,  of  the  control  (Figure  7C).  We
further examined the involvement of SCF in ECMs that have
RGD regions. The anti-SCF antibodies significantly reduced
the attachment of HCECs to the culture plates treated with
fibronectin to 78.6%, laminin to 90.3%, and type IV collagen
to 74.4% of the control, respectively (Figure 7D).
DISCUSSION
Our results showed that both SCF and c-kit were expressed in
normal  mouse  corneal  epithelial  cells,  and  that  corneal
epithelial wound healing was impaired in both Sl/Sld and W/
Wv  mice.  The  impaired  corneal  epithelial  wound  healing
process recovered after topical application of SCF to Sl/Sld
mice, a SCF mutant. These in vivo results suggested that the
SCF/c-kit  system  is  involved  in  corneal  epithelial  wound
healing.
To determine by what mechanism the SCF/c-kit system
enhanced corneal epithelial wound healing, we first examined
whether  this  system  stimulated  the  proliferation  of  the
epithelial cells. No significant difference was found in BrdU
incorporation between the wild type and W/Wv mice. This
indicated that the absence of the SCF/c-kit system does not
affect the proliferation of corneal epithelial cells.
We then examined the morphological changes in mutant
mice by SEM in vivo. The SEM results showed that the
corneal epithelial cells at the leading edge of the wound in W/
Wv  mouse  were  not  stretched  and  did  not  attach  to  the
basement membrane compared to wild type mouse. These
results suggested that the absence of the SCF/c-kit system may
retard the attachment of the cells to the basement membrane.
Figure  4.  Scanning  electron
microscopy. The leading edges of the
migrating  cells  of  corneas  from  c-kit
mutant and control WBB6F1+/+ mice,
which were collected at 6, 12, and 24 h
after  epithelial  wound  healing,  were
examined  by  scanning  electron
microscopy. The leading edge of the c-
kit mutant corneal epithelium at 24 h is
elevated (arrows), whereas that of the
WBB6F1+/+  makes  flat  lamellipodia
(arrowheads) attachments on the cornea
stroma.  +/+=WBB6F1+/+  mice,  W/
Wv=c-kit mutant mice. Bar: 100 µm.
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involved  in  cell  migration  and  cell  attachment  have  been
identified. These growth factors have been shown to regulate
the healing of the injured corneal epithelium [37-42]. Nishida
et al. [43,44] reported that EGF stimulates corneal epithelial
cell  attachment  to  fibronectin.  Later,  insulin-like  growth
factor-1  was  shown  to  promote  corneal  epithelial  cell
migration and extracellular matrices production [45,46]. More
recently, it was demonstrated that HB-EGF was more closely
involved in promoting cell migration by cell attachments than
by cell proliferation [41].
The results of our in vivo experiments suggested that the
SCF/c-kit system is most likely involved in cell migration and
cell attachment during corneal epithelial wound healing. The
most effective method of determining the exact mechanism
would be to compare the growth factors in isolated cells from
wild type and SCF- and c-kit-deficient mice. Thus, we isolated
the corneal epithelial cells from WBB6F1+/+, Sl/Sld and W/
Wv  mice  by  our  technique  [35]  and  examined  the
incorporation of BrdU and cell attachment.
As expected, enhanced cell attachment was observed in
MCECs from wild type and Sl/Sld but not in W/Wv mice. In
addition, no significant difference was detected between cells
Figure  5.  In  vitro  assay  of  BrdU
incorporation. The BrdU incorporation
rates  were  examined  with  rmSCF-
stimulated  MCECs  from  WBB6F1+/+,
SCF mutant, and c-kit mutant mice. The
BrdU  incorporation  rates  are
normalized  to  the  number  of  non-
stimulated controls (0 ng/ml rmSCF).
Error bars represent the standard error
(n=4).  There  were  no  significant
differences  between  stimulated  cells
and  non-stimulated  controls  (p>0.05,
Man-Whitney U test). +/+=WBB6F1+/+
mice,  W/Wv=c-kit  mutant  mice,  Sl/
Sld=SCF mutant mice.
Figure 6. In vitro assay of attachment
mouse  corneal  epithelial  cells
(MCECs). The effect of the rmSCF on
the  attachment  of  MCECs  from
WBB6F1+/+,  SCF  mutant,  and  c-kit
mutant  mice  was  examined.  The
MCECs were stimulated with or without
1, 10, or 30 ng/ml of rmSCF, and the
results are normalized to the number of
non-stimulated controls (0 ng/ml SCF).
Error bars represent the standard errors
(n=8). *p<0.01, +p<0.05 (Man-Whitney
U test) against non-stimulated controls.
+/+=WBB6F1+/+  mice,  W/Wv=c-kit
mutant strain, Sl/Sld=SCF mutant strain.
Molecular Vision 2012; 18:1505-1515 <http://www.molvis.org/molvis/v18/a156> © 2012 Molecular Vision
1511from  wild  type  and  from  Sl/Sld  or  W/Wv  mice  in  BrdU
incorporation in in vitro experiments.
Thus, the results of the in vivo and in vitro experiments
indicated that the SCF/c-kit system is probably involved in the
attachment of corneal epithelial cells and not cell proliferation
during wound healing. Although the function of the SCF/c-kit
system in corneal epithelia has not been determined, it has
been well shown that the SCF/c-kit system plays an important
role  in  mast  cell  and  progenitor  cell  attachment  to  the
extracellular matrix [47-52]. In the epidermis, it has been
recognized  that  SCF/c-kit  system  regulates  melanocyte
migration, differentiation, and proliferation [53,54]. In the
cornea, it has been well documented that there is an interaction
of cell adhesion molecules and ECMs controlled by other
growth  factors  during  epithelial  wound  healing  [41,45,
55-58]. It has also been demonstrated that the α6β1 integrin
expression  was  upregulated  by  HB-EGF  during  corneal
epithelial wound healing [41]. Thus, to investigate which cell
adhesion  molecules  are  regulated  by  SCF  during  corneal
epithelial  wound  healing,  we  examined  88  cell  adhesion-
related molecules by real-time PCR using Primer Array® in
an  in  vivo  wound  healing  model.  Unfortunately,  the
expression of none of the molecules examined was found to
be  changed  significantly.  Recently,  Trusolino  et  al.  [59]
proposed that growth factors could change the functional state
of integrins from inactive to acquired ligand-binding ability
with  no  changes  of  the  integrin  expression.  They  further
demonstrated  that  hepatocyte  growth  factor/scatter  factor
(HGF/SF)  induced  aggregation  and  triggering  of  efficient
ligand-binding capability of integrin αvβ3 without changing
the expression in human thyroid cells [59]. Shimizu et al.
[60] also demonstrated that the SCF/c-kit system regulates the
adhesion of intestinal epithelial cells to basement membrane
matrix  by  fibronectin  receptor,  VLA-5,  and  fibronectin
Figure 7. In vitro assay of attachment of
human corneal epithelial cells (HCECs).
The  effect  of  anti-SCF  antibodies,
tyrosine kinase inhibitor genistein, RGD
peptide, and extracellular matrix on the
attachment  of  HCECs  was  examined.
The HCECs were incubated with 0, 10,
50,  250,  or  1,000  ng/ml  of  anti-SCF
antibodies (A), 0, 5, 10, 25, or 50 µg/ml
of genistein (B), or 0, 125, 250, 500, or
1,000 µg/ml of GRGDSP or GRGESP
peptides (C). The HCECs were seeded
on  fibronectin,  laminin,  or  type  IV
collagen-coated dishes incubated with
1,000 ng/ml of anti-SCF antibodies (D).
The  results  are  normalized  to  the
number of controls. Error bars represent
the  standard  errors  (n=3).  *p<0.01,
+p<0.05 (Man-Whitney U test) against
controls.
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1512interactions. They also suggested that the adhesion was caused
by a change in the avidity or quality of VLA-5 rather than an
increase in the density of VLA-5. The authors mentioned that
the changes in the growth factor-induced avidity or affinity of
integrins  were  regulated  by  ligand-receptor  signaling
pathways.  Thus,  Simizu  et  al.  [60]  demonstrated  that
genistein, a tyrosine kinase inhibitor, significantly inhibited
the  adhesion  of  intestinal  epithelial  cells  to  fibronectin
through VLA-5. Therefore, we further examined whether the
SCF/c-kit  cell  signaling  pathway  was  involved  in  the
attachment of human corneal epithelial cells, using HCECs
for a cell attachment assay. As expected, anti-SCF Ab and
genistein significantly inhibited the attachment of HCECs,
indicating that cell adhesion was induced by the c-kit signaling
pathways  following  SCF/c-kit  interaction.  The  reduction
induced  by  RGP  peptide  indicated  the  involvement  of
integrin-ECM  interactions  on  the  adhesion  of  HCECs.
Additional experiments demonstrated that SCF/c-kit system
might enhance the avidity or affinity of integrins to adhere to
fibronectin, laminin, and type IV collagen. Although we could
not determine the particular type of integrin pairs involved in
the cell attachment, our results suggest that the SCF/c-kit
system may be involved in the cell attachment during corneal
wound healing by the induction of the avidity or affinity by
one or several members of the integrin families. To determine
the precise mechanisms, further investigations will be needed.
In conclusion, our results showed that SCF and c-kit were
expressed  in  normal  mouse  cornea,  and  they  provided
evidence that the SCF/c-kit system plays a role in corneal
wound healing by altering epithelial cell attachment.
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